BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,544 | +57.5% | 2,478 | +56.6% | 0.00% | – |
Q2 2023 | $11,137 | -74.7% | 1,582 | -70.0% | 0.00% | – |
Q1 2023 | $43,960 | -66.9% | 5,271 | -54.4% | 0.00% | – |
Q4 2022 | $132,812 | -10.3% | 11,569 | -2.1% | 0.00% | – |
Q3 2022 | $148,000 | +18.4% | 11,822 | 0.0% | 0.00% | – |
Q2 2022 | $125,000 | -94.1% | 11,822 | -90.9% | 0.00% | -100.0% |
Q1 2022 | $2,118,000 | -0.2% | 130,260 | -15.0% | 0.00% | +50.0% |
Q4 2021 | $2,122,000 | – | 153,243 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |